Digital It’s time for more tech and biotech innovation in 2023 The drive to make the UK a ‘scientific powerhouse’ was central to the government’s
R&D How decentralised storage networks can change the game for t... The way pharmaceutical companies manage data carries inherent risks, as exemplified by the constant scandals about
Digital Is the proposed Data Protection and Digital Information Bill... A new Data Protection and Digital Information Bill is currently being considered by UK ministers.
Digital A few of 2022’s biggest pharma trends – the pharmaphorum pod... As we close out the year, pharmaphorum's editorial team sat down together for a roundtable discussion of some of the biggest trends they tracked this year in the world of
Healthcare How medical device sales teams can embrace digital transform... Selling amid a global pandemic has changed the face of sales forever.
Digital Curavit’s crystal ball – how will 2023 drive meaningful chan... The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways.
News Astellas pays $285m for Audax cancer drug, and other deals Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
